OS

Oliver Schoor

IG Immatics Biotechnologies Gmbh: 528 patents #3 of 99Top 4%
IG Inmatics Biotechnologies Gmbh: 6 patents #1 of 8Top 15%
📍 Rötteln, DE: #3 of 115 inventorsTop 3%
Overall (All Time): #325 of 4,157,543Top 1%
539
Patents All Time

Issued Patents All Time

Showing 201–225 of 539 patents

Patent #TitleCo-InventorsDate
11123370 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Colette Song, Jens Fritsche +1 more 2021-09-21
11117951 Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Jens Fritsche, Harpreet Singh 2021-09-14
11117941 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-09-14
11116826 Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Toni Weinschenk, Jens Fritsche, Harpreet Singh, Andrea Mahr, Martina Ott +1 more 2021-09-14
11111280 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Andrea Mahr, Toni Weinschenk, Valentina Goldfinger, Jens Fritsche, Harpreet Singh 2021-09-07
11111281 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-09-07
11103535 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-08-31
11083784 Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Jens Fritsche, Harpreet Singh 2021-08-10
11077142 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-08-03
11071773 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-07-27
11065316 Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2021-07-20
11065315 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more 2021-07-20
11065314 Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers Andrea Mahr, Toni Weinschenk, Helen Hoerzer, Jens Fritsche, Harpreet Singh 2021-07-20
11065279 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-20
11058755 A*03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche +2 more 2021-07-13
11058754 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more 2021-07-13
11058727 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-13
11058726 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Toni Weinschenk, Anita Wiebe, Colette Song, Jens Fritsche +1 more 2021-07-13
11052114 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-06
11052113 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-07-06
11040069 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-22
11033585 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-15
11033583 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-15
11027002 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-06-08
11026977 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-06-08